Biotech Decliners: Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Aegis started coverage on shares of Recro Pharma Inc. (NASDAQ:REPH) in a research note issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $40.00 price target on the stock. Aegis’ price objective suggests a potential upside of 412.16% from the company’s current price. Recro Pharma Inc (NASDAQ:REPH) stock performance was -7.30% in last session and finished the day at $7.24. Traded … Continue reading Biotech Decliners: Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Biotech Bullish Stocks: Applied Genetic Technologies (NASDAQ:AGTC), Alder Biopharmaceuticals (NASDAQ:ALDR), Concert Pharmaceuticals (NASDAQ:CNCE), Recro Pharma Inc (NASDAQ:REPH), Relypsa (NASDAQ:RLYP)

BMO Capital Markets boosted their price target on shares of Applied Genetic Technologies Corp (NASDAQ:AGTC) from $21.00 to $34.00 in a research note issued on Monday. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ target price points to a potential upside of 34.44% from the stock’s previous close. Applied Genetic Technologies Corp (NASDAQ:AGTC) stock performance was 7.57% in last session … Continue reading Biotech Bullish Stocks: Applied Genetic Technologies (NASDAQ:AGTC), Alder Biopharmaceuticals (NASDAQ:ALDR), Concert Pharmaceuticals (NASDAQ:CNCE), Recro Pharma Inc (NASDAQ:REPH), Relypsa (NASDAQ:RLYP)

SunLink Health Systems Inc. (NYSEMKT:SSY) said that net loss for the third-quarter ended March 31, 2014 widened to $964,000 or $0.10 per share, from $186,000 or $0.02 per share last year. Loss from continuing operations for the quarter was $911,000 or $0.10 per share, compared to a loss from continuing operations of $197,000 or $0.02 per share in the prior year. Quarterly operating loss from … Continue reading Healthcare Decliners: SunLink Health Systems, Inc. (NYSEMKT:SSY), Recro Pharma Inc (NASDAQ:REPH), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Retrophin Inc (NASDAQ:RTRX)

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) has seen a massive down tick in the past few trading sessions, and analysts believe that this downward trajectory might continue for the stock and may lead it to lower levels. Short term traders can short the stock at current levels with a tight stop loss at $11 for targets of $8 or lower. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock performance was … Continue reading Biotech Bullish Stocks: Galmed Pharmaceuticals Ltd (NASDAQ:GLMD), Reliv International, Inc (NASDAQ:RELV), Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX)

Biocept Inc (NASDAQ:BIOC) has appointed Raaj Trivedi as vice president of commercial operations. Biocept Inc (NASDAQ:BIOC) stock performance was -9.62% in last session and finished the day at $6.39. Traded volume was 24,173.00million shares in the last session and the average volume of the stock remained 47.03K shares. Biocept Inc (NASDAQ:BIOC) insider ownership is 0.40%. On March 12, 2014, Recro Pharma, Inc. (NASDAQ:REPH) completed its … Continue reading Healthcare Watch list: Biocept Inc (NASDAQ:BIOC), Recro Pharma Inc (NASDAQ:REPH), Eagle Pharmaceuticals Inc (NASDAQ:EGRX), Trevena Inc (NASDAQ:TRVN)

On March 12, 2014, Recro Pharma, Inc (NASDAQ:REPH) completed its initial public offering (“IPO”). In relation to such IPO, the Company filed information reflected in a slide presentation as a free writing prospectus on February 13, 2014. Recro Pharma Inc (NASDAQ:REPH) stock performance was -4.64% in last session and finished the day at $6.98. Traded volume was 43.6K shares in the last session and the … Continue reading Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)